While there is a slight increase in the DMF fee from US$ 95,084 in 2025 to US$ 102,584 in 2026, the ANDA fee has seen a sharp rise: from US$ 321,920 in 2025 to US$ 358,247 in 2026.FY 2025 and FY 2026 User Fee Rates Generic drug fee category Fees rates for FY 2025 Fees rates for FY 2026 Applications: Abbreviated New Drug Application (ANDA) US$ 3,21,920 US$ 3,58,247 Drug Master File (DMF) US$ 95,084 US$ 1,02,584 Facilities: Active Pharmaceutical Ingredient (API)Domestic US$ 41,580 US$ 43,549 APIForeign US$ 56,580 US$ 58,549 Finished Dosage Form (FDF)Domestic US$ 2,31,952 US$ 2,38,943 FDFForeign US$ 2,46,952 US$ 2,53,943 Contract Manufacturing Organization (CMO)Domestic US$ 55,668 US$ 57,346 CMOForeign US$ 70,668 US$ 72,346 GDUFA Program: Large size operation generic drug applicant US$ 18,91,664 US$ 19,18,377 Medium size operation generic drug applicant US$ 7,56,666 US$ 7,67,351 Small business generic drug applicant US$ 1,89,166 US$ 1,91,838 Our viewFor several years prior to the pandemic, India had a lead in Type II DMF submissions
Bibcode:1969PNAS...62..461B
The use of polygenic risk scores (PRSs), which summarize the effect of multiple common genetic risk variants across the genome, has further contributed to our understanding of the genetic relationship between MDD and T2DM
Using peptides without knowing what you are treating is like putting premium fuel in a car with a flat tire
